Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

2.

Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma.

Jiang A, Gao X, Zhang D, Zhang L, Lu H.

Oncol Lett. 2013 Aug;6(2):375-380.

3.
4.

[Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].

Liao DW, Wang L, Zhang XG, Liu MQ.

Ai Zheng. 2006 Oct;25(10):1238-42. Chinese.

PMID:
17059767
5.

Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.

Xu XY, Lin N, Li YM, Zhi C, Shen H.

Pathol Res Pract. 2013 Jun;209(6):345-52. doi: 10.1016/j.prp.2013.02.015.

PMID:
23602236
6.

Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells.

Zito CR, Jilaveanu LB, Anagnostou V, Rimm D, Bepler G, Maira SM, Hackl W, Camp R, Kluger HM, Chao HH.

PLoS One. 2012;7(2):e31331. doi: 10.1371/journal.pone.0031331.

7.

Prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer.

Mayadagli A, Karabulut Gul S, Bilici A, Fatih Oruc A, Kocak M, Ozkan A, Aksu A, Ozdemir Barisik N, Gumus M.

J BUON. 2014 Jan-Mar;19(1):157-63.

PMID:
24659658
8.

Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer.

Chen ZL, Zhao SH, Wang Z, Qiu B, Li BZ, Zhou F, Tan XG, He J.

Chin J Cancer. 2011 Jan;30(1):62-8.

9.

Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis.

Xu YJ, Shao YF, Zhao X, Geng YT, Wang K, Yin YM.

J Cancer Res Clin Oncol. 2011 Dec;137(12):1841-8. doi: 10.1007/s00432-011-1054-5.

PMID:
21927908
10.

[Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].

Zhang Y, Liu YP, Du K, Wang H, Wang XL.

Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):594-8. Chinese.

PMID:
22325219
11.

Overexpression of NEDD9 is associated with altered expression of E-Cadherin, ╬▓-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.

Miao Y, Li AL, Wang L, Fan CF, Zhang XP, Xu HT, Yang LH, Liu Y, Wang EH.

Pathol Oncol Res. 2013 Apr;19(2):281-6. doi: 10.1007/s12253-012-9580-2.

PMID:
23086683
12.

Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.

Sun PL, Jin Y, Kim H, Seo AN, Jheon S, Lee CT, Chung JH.

Virchows Arch. 2013 Sep;463(3):427-36. doi: 10.1007/s00428-013-1462-9.

PMID:
23907568
13.
14.

Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.

Luo Z, Wu RR, Lv L, Li P, Zhang LY, Hao QL, Li W.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):3632-46. Review.

15.

[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].

Pfannschmidt J, Muley T, Hoffmann H, B├╝lzebruck H, Dienemann H.

Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. German.

PMID:
17109272
16.

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.

Lung Cancer. 2008 Oct;62(1):113-9. doi: 10.1016/j.lungcan.2008.02.014.

PMID:
18550205
17.

Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors.

Su LL, Ma WX, Yuan JF, Shao Y, Xiao W, Jiang SJ.

Chin Med J (Engl). 2012 Nov;125(22):4003-8.

18.

Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.

Al-Saad S, Donnem T, Al-Shibli K, Persson M, Bremnes RM, Busund LT.

Anticancer Res. 2009 Oct;29(10):4175-83.

19.

[Clinicopathological Research and Expression of PTEN/PI3K/Akt Signaling Pathway in Non-small Cell Lung Cancer.].

Shu H, Zhang H, Xu C, Zhao X.

Zhongguo Fei Ai Za Zhi. 2009 Aug 20;12(8):889-92. doi: 10.3779/j.issn.1009-3419.2009.08.11. Chinese.

20.

A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.

Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.

BJU Int. 2012 Dec;110(11 Pt C):E1237-48. doi: 10.1111/j.1464-410X.2012.11569.x.

Items per page

Supplemental Content

Support Center